About
Cognito Therapeutics, Inc. is a medical technology company based in Cambridge, Massachusetts, focused on developing innovative therapies for neurodegenerative diseases, particularly Alzheimer’s disease. Founded in 2016, the company utilizes advanced research in neuroscience and optogenetics to create non-invasive treatments aimed at enhancing cognitive and functional abilities in patients. The core technology of Cognito Therapeutics involves gamma wave stimulation, which targets abnormal neuronal activity associated with Alzheimer’s. Their investigational therapeutic platform is delivered through a wearable headset that provides visual and auditory sensory stimulation to evoke gamma wave activity. This approach has shown promising results in clinical trials, including a significant slowing of brain volume loss and functional decline in patients with mild to moderate Alzheimer’s disease. The device has received FDA Breakthrough Device Designation, highlighting its potential to meet critical medical needs in Alzheimer’s treatment.
Technologies
Keywords
Company Information
- Employees51
- Founded2016
- Annual Revenue$3200000
- Total Funding$227015297
Location
1218 Massachusetts Ave, Cambridge, Massachusetts, United States, 02138-3821
